BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1932347)

  • 21. AFM study of membrane proteins, cytochrome P450 2B4, and NADPH-cytochrome P450 reductase and their complex formation.
    Kiselyova OI; Yaminsky IV; Ivanov YD; Kanaeva IP; Kuznetsov VY; Archakov AI
    Arch Biochem Biophys; 1999 Nov; 371(1):1-7. PubMed ID: 10525282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidation of low molecular weight chloroalkanes by cytochrome P450CAM.
    Lefever MR; Wackett LP
    Biochem Biophys Res Commun; 1994 May; 201(1):373-8. PubMed ID: 8198597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidation of diethyldithiocarbamate to disulfiram by liver microsomal cytochrome P-450-containing monooxygenase system.
    Masuda Y; Nakamura Y
    Res Commun Chem Pathol Pharmacol; 1989 Oct; 66(1):57-67. PubMed ID: 2559440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inactivation of glutamine synthetase by a purified rabbit liver microsomal cytochrome P-450 system.
    Nakamura K; Oliver C; Stadtman ER
    Arch Biochem Biophys; 1985 Jul; 240(1):319-29. PubMed ID: 2861789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional interactions in cytochrome P450BM3: flavin semiquinone intermediates, role of NADP(H), and mechanism of electron transfer by the flavoprotein domain.
    Murataliev MB; Klein M; Fulco A; Feyereisen R
    Biochemistry; 1997 Jul; 36(27):8401-12. PubMed ID: 9204888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the hydrophobic tail of cytochrome b5 in the interaction with cytochrome P-450 LM2.
    Bendzko P; Usanov SA; Pfeil W; Ruckpaul K
    Acta Biol Med Ger; 1982; 41(4):K1-K8. PubMed ID: 7124244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism-based inactivation of the major beta-naphthoflavone-inducible isozyme of rat liver cytochrome P-450 by the chloramphenicol analog N-(2-p-nitrophenethyl)dichloroacetamide.
    Miller NE; Halpert JR
    Drug Metab Dispos; 1987; 15(6):846-51. PubMed ID: 2893712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Directed modification of the structure of cytochrome P-450 substrates as a method of generating new inducers of the microsomal monooxygenase system].
    Tsyrlov IB; Gerasimov KE; Gutkina NI; Liakhovich VV
    Biokhimiia; 1987 Aug; 52(8):1307-14. PubMed ID: 3663765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cytochrome P-450 and oxidative modification of macromolecules].
    Archakov AI; Adrianov NV; Karuzina II
    Vestn Akad Med Nauk SSSR; 1990; (2):21-7. PubMed ID: 2162582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical modification of cytochrome P-450 LM2 with N-acetylimidazole. Evidence for the functional involvement of tyrosyl residues.
    Jänig GR; Friedrich J; Smettan G; Bernhardt R; Ristau O; Ruckpaul K
    Biomed Biochim Acta; 1985; 44(7-8):1071-82. PubMed ID: 4084263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of microenvironment and formation of intra-molecular links on the tertiary structure of cytochrome P-450 LM2].
    Uvarov VIu; Leshchenko AV; Rukavishnikov IG; Dzhuzenova ChS; Archakov AI
    Biokhimiia; 1988 Sep; 53(9):1433-8. PubMed ID: 3203105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heme enhances hexobarbital metabolism in perfused rat liver after drug-mediated destruction of cytochrome P-450.
    Farrell GC; Gollan JL; Correia MA; Schmid R
    J Pharmacol Exp Ther; 1981 Aug; 218(2):363-7. PubMed ID: 7252836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxygen activation by cytochrome P450BM-3: effects of mutating an active site acidic residue.
    Yeom H; Sligar SG
    Arch Biochem Biophys; 1997 Jan; 337(2):209-16. PubMed ID: 9016815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The flavoprotein domain of P450BM-3: expression, purification, and properties of the flavin adenine dinucleotide- and flavin mononucleotide-binding subdomains.
    Sevrioukova I; Truan G; Peterson JA
    Biochemistry; 1996 Jun; 35(23):7528-35. PubMed ID: 8652532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Selective chemical modification of cholesterol hydroxylating cytochrome P-450 from adrenal cortex mitochondria by tetranitromethane].
    Usanov SA; Pikuleva IA; Chashchin VL; Akhrem AA
    Bioorg Khim; 1984 Jan; 10(1):32-45. PubMed ID: 6091677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biotransformation of N,N',N''-triethylenethiophosphoramide: oxidative desulfuration to yield N,N',N''-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase.
    Ng SF; Waxman DJ
    Cancer Res; 1990 Feb; 50(3):464-71. PubMed ID: 2105156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction and catalytic properties of cytochrome P-450 LM2 in reconstituted system containing monomeric carriers.
    Kanaeva IP; Skotselyas ED; Turkina IF; Petrochenko EV; Davydov DR; Kondrashin SK; Dzuzenova ChS; Bachmanova GI; Archakov AI
    Biochem Biophys Res Commun; 1987 Sep; 147(3):1295-9. PubMed ID: 3663218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivation of key metabolic enzymes by mixed-function oxidation reactions: possible implication in protein turnover and ageing.
    Fucci L; Oliver CN; Coon MJ; Stadtman ER
    Proc Natl Acad Sci U S A; 1983 Mar; 80(6):1521-5. PubMed ID: 6572914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydrogen peroxide-mediated inactivation of microsomal cytochrome P450 during monooxygenase reactions.
    Karuzina II; Archakov AI
    Free Radic Biol Med; 1994 Dec; 17(6):557-67. PubMed ID: 7867972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The oxidative inactivation of cytochrome P450 in monooxygenase reactions.
    Karuzina II; Archakov AI
    Free Radic Biol Med; 1994 Jan; 16(1):73-97. PubMed ID: 8299999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.